SK Co., Ltd. sold 11% of SK Biopharm’s stake to KRW 1,1163 trillion, invested in the entire new growth business
Service Report under the Prime Minister’s Office “Investing in North Korea’s Energy with KRW 7.2 trillion in Domestic Funds”